The detection of local recurrent head and neck cancer with fluroine-18 fluoradeoxyglucose dual-head positron emission tomography

European Journal of Nuclear Medicine

Volumn 26, Issue 7, 1999, Pages 767-773

  Stokkel, Marcel P M ^a   Terhaard, Chris H J ^b   Hordijk, Gerrit Jan ^b   Van Rijk, Peter P ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Fluorodeoxyglucose; Laryngeal carcinoma; Local recurrence; Positron emission tomography; Single photon emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ARTIFACT; BIOPSY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; FEMALE; GENERAL ANESTHESIA; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; HYPOPHARYNX CANCER; LARYNX CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; SWALLOWING;

FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032774931     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050448     Document Type: Article

References (24)

1. Kaanders JHAM, Pop LAM, Marres HAM, Liefers J, van den Hoogen FJA, van Daal WAJ, van der Kogel AJ. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol 1998; 48: 115-122.
2. Bronstein AD, Nyberg DA, Schwartz AN, Schuman WP, Griffin BR. Soft tissue changes after head and neck radiation: CT findings. AJNR 1989; 10: 171-175.
3. Gussack GS, Hudgin PA. Imaging modalities in recurrent head and neck tumors. Laryngoscope 1991; 101: 119-124.
4. Harnsberger H, Mancuso A, Muraki A, Parkin J. The upper aerodigestive tract and neck: CT evaluation of recurrent tumors. Radiology 1983; 149: 403-409.
5. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Hoh C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992; 102: 281-288.
6. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2[F-18]-fluoro-D-glucose PET and MR imaging diagnosis. Radiology 1996; 200: 135-141.
7. Stokkel MP, Terhaard CH, Mertens IJ, Hordijk GJ, van Rijk PP. Fluorine-18-FDG detection of laryngeal cancer post-radiotherapy using dual-head coincidence imaging. J Nucl Med 1998; 39: 1385-1387.
8. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32: 1548-1555.
9. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer 1988; 61: 1776-1781.
10. Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995; 36: 252-258.
11. Greven KM, Williams DW, Keyes JW, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74: 1355-1359.
12. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197: 205-211.
13. McGuirt WF, Greven KM, Williams DW, Kyes JW, Watson N. Laryngeal radionecrosis versus recurrent cancer: a clinical approach. Ann Otol Rhinol Laryngol 1998; 107: 293-296.
14. Shreve PD, Steventon RS, Deters EC, Kison PV, Gross MD, Wahl RL. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-437.
15. Delbeke D, Patton JA, Martin WH, Sandler MP. FDG-PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. J Nucl Med 1999; 40: 110-117.
16. 18F-FDG using a dual head coincidence camera [abstract]. Eur J Nucl Med 1998; 25: 1032.
17. Sugawara Y, Braun DK, Kison PV, et al. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25: 1238-1243.
18. Slosman DO, Spiliopoulos A, Keller A, et al. Quantitative metabolic PET imaging of a plasma cell granuloma. J Thorac Imaging 1994; 2: 116-119.
19. Bakheet SMB, Powe J. Fluorine-18-Fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer. J Nucl Med 1996; 39: 234-236.
20. Patz EF Jr, Lowe VJ, Huffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 2: 487-490.
21. Yamada Y, Uchida Y, Tatsumi K, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 1998; 39: 1160-1166.
22. Engel H, Steinert H, Buck A, et al. Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 1996; 37: 441-446.
23. Kostaglu L, Wong JCH, Barrington SF, et al. Speech-related visualization of laryngeal muscles with fluorine-18-FDG. J Nucl Med 1996; 37: 1771-1773.
24. Tahiro M, Fujimoto T, Kubota K, et al. F18 FDG-PET imaging of muscle activity of runners. J Nucl Med 1998; 39: 195P.